In general, variants in the GABRG2 result in a broad spectrum of phenotypic severity, ranging from asymptomatic, FS, genetic epilepsy with febrile seizures plus (GEFS+), and Dravet syndrome individuals. Here, GABRG2 is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.